Wednesday 26 June 2019

Newcastle BRC co-funds new Clinical Research Associate post as part of EMINENT initiative

Newcastle University is now advertising for a Clinical Research Associate in Rheumatology, co-funded by the NIHR Newcastle Biomedical Research Centre (BRC) and GlaxoSmithKline.

The Newcastle BRC is co-funding a new Clinical Research Associate post in partnership with GlaxoSmithKline (GSK) to be held in the Institute of Cellular Medicine, Faculty of Medical
Sciences (Newcastle University) in order to further research into the area of rheumatology. The successful applicant will have the opportunity to gain unique hands-on experience in translational medicine, working directly with GSK and a range of academic collaborators. More information about the advertised vacancy can be found on the University’s website and the closing date for applications is 14th July 2019.

The Clinical Research Associate post at Newcastle University is one of four prestigious fully-funded, BRC-MRC-GSK Clinical Research Fellowship-PhD studentships offered through the Experimental Medicine Initiative to Explore New Therapies (EMINENT); the other three posts will be held at the Imperial College London, University of Glasgow and University College London respectively.

Cross-sector partnership between research and industry

EMINENT is a co-funded programme which brings together investigators and researchers from universities and industry to undertake novel science that would not be possible outside such a cross-sector network. Academic researchers gain unprecedented access to GSK’s unlicensed asset portfolio, via collaborative pre-clinical and experimental medicine studies aimed at enhancing the understanding of disease mechanisms and accelerating the development of novel therapeutics for patients in under-served disease areas. The overarching aim of EMINENT is to deliver significant scientific progress, to understand disease mechanisms, and develop new therapeutic strategies.

Building capacity for research for the future

The EMINENT training programme aims to deliver a cadre of highly skilled experimental medicine leaders of the future. The scheme provides a novel 3-year PhD training programme for clinical fellows, which includes dedicated time embedded within GSK, annual research retreats, a tailored programme of teaching covering topics such as clinical trial design, drug discovery pathways, intellectual property management, data science, and novel technology platforms, alongside joint mentorship by senior researchers from both academia and industry.